Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom 
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push 
Apple Turns 50: From Garage Startup to AI Crossroads 
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk 
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 
Britain Courts Anthropic Amid US Defense Department Dispute 
CHICAGO, July 25, 2017 -- John Cherf, MD, MPH, MBA, chief of orthopedics at Advocate Illinois Masonic Medical Center, and Julie Schulz, MD, MPH, Procured Health vice president, will present “Leveraging Evidence-Based Medicine to Reduce Clinical Costs and Improve Outcomes” on Wednesday, July 26, at the AHRMM17 Conference in Washington, D.C.
“Collaboration between hospitals and physicians is essential to improving cost, quality and outcomes,” Dr. Cherf said. “Using reliable evidence to drive discussions about device selection and new technology adoption ensures that the conversation is objective, vendor neutral and focused on providing the best care possible.”
During their presentation, Dr. Cherf and Dr. Schulz will highlight:
- How taking an evidenced-based approach can guide clinical conversations around product selection and action
- Innovative tips and best practices to better engage physicians in discussions about device selection
- Advocate Health Care's physician-led, patient-centered approach to reducing clinical variation in spine care
“In one year alone, U.S. health systems overspend on medical supplies and devices by an estimated $35 billion, due to both inflated prices and overuse of premium products,” Dr. Schulz said. “Many hospitals believe that if they limit device selection, physicians will choose to practice elsewhere, but Procured Health’s research doesn’t support this belief. Physicians are eager to use products that improve care, as supported by clinical evidence.”
Hosted by the Association for Healthcare Resources and Materials Management, AHRMM17 is the leading education event for individuals and organizations working to improve cost, quality and outcomes in healthcare supply chain.
About Procured Health
Procured Health is at the forefront of helping health systems achieve the best clinical outcomes at an optimal cost by making clinical evidence accessible and actionable. Providers across the U.S. rely on Procured Health's technology platform to make better decisions on spend and usage of medical devices, supplies, and drugs.
For more information, visit ProcuredHealth.com, find us on LinkedIn, follow @ProcuredHealth on Twitter and like us on Facebook.
Procured Health [email protected] (312) 300-7899
